GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
B

Bright Minds Biosciences DRUG · USD

Health Care · US listing · 🇺🇸 United States

Compare

24.11

+4.83%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Latest on Bright Minds Biosciences

Our reporting

Next results

22 Dec 2026

Due on 22 Dec 2026. Analysts expect earnings of -1.07 a share.

Past results

Reported against what analysts expected

17 Aug 202614 Aug 202613 Aug 202620 May 202619 May 202612 Feb 2026
Earnings per share-0.17-0.17-0.53-0.80-0.80-0.70
Forecast-1.22-1.39-1.39-1.06-1.17-0.98

Key events

  1. 22 Mar 2021Listed

Sources and methodology

Data on this tab
Our reporting and our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.